Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor

Agonist binding to G protein‐coupled receptors is believed to promote a conformational change that leads to the formation of the active receptor state. However, the character of this conformational change which provides the important link between agonist binding and G protein coupling is not known. Here we report evidence that agonist binding to the β2 adrenoceptor induces a conformational change around 125Cys in transmembrane domain (TM) III and around 285Cys in TM VI. A series of mutant β2 adrenoceptors with a limited number of cysteines available for chemical derivatization were purified, site‐selectively labeled with the conformationally sensitive, cysteine‐reactive fluorophore IANBD and analyzed by fluorescence spectroscopy. Like the wild‐type receptor, mutant receptors containing 125Cys and/or 285Cys showed an agonist‐induced decrease in fluorescence, while no agonist‐induced response was observed in a receptor where these two cysteines were mutated. These data suggest that IANBD bound to 125Cys and 285Cys are exposed to a more polar environment upon agonist binding, and indicate that movements of transmembrane segments III and VI are involved in activation of G protein‐coupled receptors.

[1]  A. Scheer,et al.  The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Brian K. Kobilka,et al.  Structural Instability of a Constitutively Active G Protein-coupled Receptor , 1997, The Journal of Biological Chemistry.

[3]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[4]  T. Schwartz,et al.  Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering. , 1996, The EMBO journal.

[5]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[6]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[7]  A. IJzerman,et al.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Manuel Peitsch,et al.  Probing the Structure and Function of the Tachykinin Neurokinin-2 Receptor through Biosynthetic Incorporation of Fluorescent Amino Acids at Specific Sites* , 1996, The Journal of Biological Chemistry.

[9]  A. Scheer,et al.  Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.

[10]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[11]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[12]  M. Maze,et al.  Arrangement of Transmembrane Domains in Adrenergic Receptors , 1996, The Journal of Biological Chemistry.

[13]  Kenneth A Jacobson,et al.  Molecular architecture of G protein‐coupled receptors , 1996, Drug development research.

[14]  H. Weinstein,et al.  Conformational Memories and the Exploration of Biologically Relevant Peptide Conformations: An Illustration for the Gonadotropin-Releasing Hormone , 1996 .

[15]  A. Strosberg,et al.  Carazolol: a potent, selective β3-adrenoceptor agonist , 1995 .

[16]  B. Kobilka,et al.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.

[17]  M. Menziani,et al.  Molecular dynamics simulations of m3-muscarinic receptor activation and QSAR analysis. , 1995, Bioorganic & medicinal chemistry.

[18]  B. Kobilka Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. , 1995, Analytical biochemistry.

[19]  J. Wess,et al.  Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors (*) , 1995, The Journal of Biological Chemistry.

[20]  H. Khorana,et al.  Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.

[21]  Frank Guarnieri,et al.  Conformational memories and a simulated annealing program that learns: Application to LTB4 , 1995, J. Comput. Chem..

[22]  Jonathan A Javitch,et al.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.

[23]  B. Roth,et al.  Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. , 1995, Molecular pharmacology.

[24]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[25]  H. Weinstein,et al.  Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor. , 1994, Protein engineering.

[26]  K. Fahmy,et al.  A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.

[27]  T. Schwartz,et al.  Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.

[28]  E. Jacoby,et al.  Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences. , 1994, Journal of receptor research.

[29]  R. Graham,et al.  The high affinity state of the beta 2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. , 1994, The Journal of biological chemistry.

[30]  K Konvicka,et al.  A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.

[31]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[32]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[33]  Gebhard F. X. Schertler,et al.  Projection structure of rhodopsin , 1993, Nature.

[34]  H Weinstein,et al.  Signal transduction by a 5-HT2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. , 1993, Journal of medicinal chemistry.

[35]  J. Baldwin The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[36]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[37]  G Vriend,et al.  Modeling of transmembrane seven helix bundles. , 1993, Protein engineering.

[38]  T. S. Kobilka,et al.  Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.

[39]  B. Kobilka,et al.  Identification of intramolecular interactions in adrenergic receptors. , 1992, The Journal of biological chemistry.

[40]  M. Caron,et al.  Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. , 1992, The Journal of biological chemistry.

[41]  J Hoflack,et al.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.

[42]  T P Lybrand,et al.  Three-dimensional structure for the beta 2 adrenergic receptor protein based on computer modeling studies. , 1992, Journal of molecular biology.

[43]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.

[44]  B. Kobilka,et al.  Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.

[45]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[46]  M. Caron,et al.  G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Kobilka,et al.  Construction and expression of chimeric receptors to understand the structure-function relationships in adrenergic receptors , 1991 .

[48]  J. Wess,et al.  Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.

[49]  H. Khorana,et al.  Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. , 1991, The Journal of biological chemistry.

[50]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[51]  C. Strader,et al.  Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor. , 1991, Trends in pharmacological sciences.

[52]  M. Caron,et al.  Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.

[53]  M. Caron,et al.  Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. , 1989, The Journal of biological chemistry.

[54]  C. Fraser Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. , 1989, The Journal of biological chemistry.

[55]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[56]  M. Caron,et al.  The mammalian beta 2-adrenergic receptor: purification and characterization. , 1984, Biochemistry.

[57]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[58]  A. Strosberg,et al.  Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. , 1979, The Journal of biological chemistry.